Skip to content
Peptigraph home

Is retatrutide a steroid?

No: retatrutide (LY3437943) is described as a single peptide with agonist activity at the glucagon, GIP and GLP-1 receptors, not as a steroid.

GLP-1 / GIP / glucagon triple agonistUpdated

Short answer

No: retatrutide (LY3437943) is described as a single peptide with agonist activity at the glucagon, GIP and GLP-1 receptors, not as a steroid.[1]

What it is instead

A review calls it a first-in-class, unimolecular triple hormone receptor agonist at the GIP, GLP-1 and glucagon receptors.[2]

A review of unregulated injectables names the veterinary anabolic steroid trenbolone and the investigational triple agonist retatrutide as separate items in the same list.[3]

More on Retatrutide

Sources

  1. 1LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.Lancet (London, England) · 2022PMID 36354040Accessed 2 Oct 2026
  2. 2Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review.Cardiology in review · 2026PMID 42108533Accessed 2 Oct 2026
  3. 3Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.Missouri medicine · 2026PMID 42757290Accessed 2 Oct 2026

Found an error? Report a correction.